安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- investors. biontech. de
Effective one day following the cancellation, BioNTech will cause New Topco to elect to be disregarded as an entity separate from BioNTech for U S federal income tax purposes, which we refer to as the New Topco U S tax election
- BioNTech
BioNTech führt Sie durch die spannende Welt der Immuntherapien Hier finden Sie Informationen zur Grundlagenforschung und zu neuartigen Behandlungsmöglichkeiten
- 2025-26 COVID-19 Vaccine for Age 5 to 11 Years - MN Dept. of Health
The nurse will implement this protocol for COVID-19 vaccination using the 2025-26 Pfizer-BioNTech and Moderna COVID-19 vaccine products for 5 through 11 years of age
- New York State Department of Health
Procedure: This standing order is for use of Pfizer-BioNTech COVID-19 Vaccine (2025-2026 Formula) prefilled, single-dose syringes for persons 5 years and older administered intramuscularly and a single dose is 0 3 mL supplied in prefilled syringes
- Vaccination protocol for COVID-19 mRNA Vaccine BNT162b2 (Pfizer . . .
SPPG and PHA have developed this protocol for authorisation by the Northern Ireland Minister for Health to facilitate the delivery of the national influenza immunisation programme in Northern Ireland
- The Commonwealth of Massachusetts
If it is not feasible to adhere to the recommended interval and a delay in vaccination is unavoidable, the second dose of Pfizer-BioNTech and Moderna COVID-19 vaccines may be administered up to 6 weeks (42 days) after the first dose
- 2025-26 Moderna COVID-19 Vaccine for Age 6 Months through 4 Years
To reduce incidence of morbidity and mortality of COVID-19 disease Policy of protocol The nurse will implement this protocol for COVID-19 vaccination using the 2025-26 Moderna Spikevax vaccine product for people 6 months through 4 years old
- Rolling-review-report-new-active-substance-status-template-rev-04. 2020
Rapporteur Rolling Review critical assessment report Assessment report on the claim of new active substance (NAS) status of 5’capped mRNA encoding full length SRAS-CoV-2 Spike protein contained in COVID-19 mRNA Vaccine BioNTech International non-proprietary name: Not yet assigned
|
|
|